Oct 2026· Experimental Gerontology· pp.
113373
· 0 citations
Medicine
TL;DR
The roles of ubiquitin proteasome system, autophagy lysosomal pathway, and unfolded protein response in muscle wasting are analyzed, highlighting protein loss from synthesis-degradation imbalance as a major driver of muscle atrophy under catabolic conditions.
Abstract
Aging is a universal biological process signified by a time-dependent decline in physiological activity, driven by molecular and cellular damage, leading to greater susceptibility to diseases and fatal outcomes. Impaired proteostasis is a key aspect of cellular aging in which the cells become less efficient at folding, repairing, and recycling proteins, consequently inducing accumulation of damaged and aggregation-prone proteins. The onset of muscle loss is driven by a reduction in protein synthesis, heightened activation of proteolytic pathways, and elevated ER stress factors, collectively contributing to functional decline and increased vulnerability with aging. Muscle atrophy, whether age-related or driven by chronic illness, represents a major role in defective health, impacting both quality of life and survival. This review explores the intricate and multidimensional nature of proteostasis network regulating protein quality control across skeletal muscles. We examined how the malfunction of components within proteostasis networks during aging contributes to the induction, progression, and chronicity of common age-related muscle wasting. Experimental and clinical studies exploring potential therapeutic strategies for better proteostasis in muscle wasting have been discussed. In this review, we emphasized the increasing demand for effective therapeutic interventions that can slow down or mitigate age-related deterioration in muscle physiology and sustain mobility and quality of life in the elderly. We analyzed the roles of ubiquitin proteasome system, autophagy lysosomal pathway, and unfolded protein response in muscle wasting, highlighting protein loss from synthesis-degradation imbalance as a major driver of muscle atrophy under catabolic conditions. This review outlines key findings with emerging insights to help drive the development of targeted therapies against muscle wasting. Looking ahead, emerging approaches such as PROTACs, extracellular vesicle-based therapies, and artificial intelligence-driven predictive models hold promise for advancing precision interventions in muscle wasting research.
Aging progressively impairs skeletal muscle function, leading to sarcopenia, frailty, and loss of independence. Although oxidative stress has long been considered a central driver of muscle aging, increasing evidence indicates that reactive oxygen species (ROS) also serve essential signaling functions that coordinate m...
E. Tamayo-Torres, Miriam Martinez-Canton, Silvana Soto-Rodriguez et al.· Free Radical Biology & Medic...· 0 citations
Skeletal muscle aging is a major cause of frailty, metabolic dysfunction, and loss of independence in later life, yet it cannot be explained by muscle mass loss alone. Recent single‐cell, multi‐omics, and translational studies show that aged muscle is shaped by coordinated changes in myofibers, stem and stromal cells,...
Abstract Proteostasis, the process governing the dynamic regulation of protein synthesis, folding and degradation, is critical for maintaining cell function and organismal health. Ageing disrupts this intricate system, leading to inactive, misfolded and/or aggregated proteins that contribute to age-associated pathologi...
Neethu Babu, K. Whalen, Brian Freeman· Philosophical transactions o...· 1 citation
It is shown that antisense oligonucleotide-mediated inhibition of miR-128-3p restores muscle mass and function in aged mice, improves cardiac function while limiting adverse remodeling following myocardial infarction, and ameliorates skeletal and cardiac muscle pathology in mouse and pig models of Duchenne muscular dys...
Melissa A. Boldridge, Lei Xu, Xiao-Yin Wang et al.· bioRxiv· 0 citations
This review summarizes the intrinsic mechanisms driving skeletal muscle aging, including protein turnover imbalance and anabolic resistance, myosteatosis, denervation and motor unit loss, and cellular composition remodeling and highlights emerging interventions targeting skeletal muscle aging.
Mei-Mei Li, Xin-Wei Liu, Yi-Xuan Li et al.· Biomolecules· 0 citations
Sarcopenia is a progressive degenerative disease of skeletal muscle closely associated with aging, disuse, and chronic diseases, affecting approximately 10–16% of the global older adult population. Its core pathological basis lies in the disruption of skeletal muscle cell proteostasis and mitochondrial dysfunction. At...
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.